Abstract: The present invention is directed to compressed hemostatic tablets or forms comprising a fibrous non-woven oxidized cellulose (OC or ORC) multilayer material compressed into a form stable tablet, further comprising calcium salt, with the tablets rapidly expandable on contact with blood or blood plasma. The compressed forms may further comprise a multi-arm PEG-SG and are dimensionally, preferably with regard to length and width, stable for at least 48 hours after compression. In some embodiments, the compressed forms will expand upon contact with blood from 1.5 to 5 times of tablet length in 5 seconds; from 2 to 6 times of tablet length in 20 seconds; and from 3 to 6 times of tablet length in 5 minutes. The compressed forms are effective in hemostasis in heparinized blood.

Abstract: A method and apparatus for incentivizing a user to update a device is provided herein. During operation, an update manager will determine a past history of performance problems specific to the device that needs updating. The device manager will also determine problems fixed with the update. A personalized message that mentions the past history of performance problems that are fixed with the update will be provided to the user along with a request to update the device.

Abstract: Imaging agents comprising an isolated polypeptide conjugated with a radionucleide and a chelator; wherein the isolated polypeptide binds specifically to HER2, or a variant thereof; and methods for preparing and using these imaging agents.

Abstract: A light-transmitting antenna includes a substrate, a first and a second conductive pattern. The first and the second conductive pattern is disposed on a first and a second surface of the substrate respectively. The first conductive pattern includes a first feeder unit, a first and a second radiation unit, a first and a second coupling unit and a first parasitic unit. The first feeder unit is connected to the second radiation unit. The first and the second radiation unit are located between the first and the second coupling unit. One side and the other side of the first parasitic unit is connected to the second coupling unit and adjacent to the first coupling unit respectively. The second conductive pattern includes a second feeder unit, a third coupling unit, a second parasitic unit, and a fourth coupling unit.

Abstract: A circuit check method and an electronic apparatus applicable to a to-be-tested circuit are provided. The to-be-tested circuit has one or more first nodes related to a gate voltage of one or more transistor devices and a plurality of second nodes. The circuit check method includes: setting endpoint voltages of a plurality of input interface ports of the to-be-tested circuit; obtaining a first node voltage of the first node according to a conduction path of the to-be-tested circuit and the gate voltage of the transistor device; obtaining a second node voltage of each second node according to the conduction path, the endpoint voltages, and the first node voltage; and performing circuit static check on the to-be-tested circuit by applying the first node voltage and the second node voltage.

Abstract: A light-transmitting antenna includes a substrate, a first conductive pattern, and a second conductive pattern. The first conductive pattern has a first feeder unit, a first radiation unit, a second radiation unit, and a first connection unit. The first feeder unit and the first connection unit are connected to two sides of the first radiation unit. The first connection unit connects the first radiation unit and the second radiation unit. The second conductive pattern has a second feeder unit, a third radiation unit, a fourth radiation unit, and a second connection unit. The second feeder unit and the second connection unit are connected to two sides of the third radiation unit. The second connection unit connects the third radiation unit and the fourth radiation unit. An orthogonal projection of the second feeder unit on a first surface of the substrate at least partially overlaps the first feeder unit.

Abstract: The present disclosure discloses a display driving method, a display driver chip and a liquid crystal display device. The display driving method includes: within a display duration of a first bit-plane data, controlling the display device to display the first bit-plane data; when a loading duration of a single bit-plane data is longer than the display duration of the first bit-plane data, after completing the display of the first bit-plane data, controlling a pixel liquid crystal layer corresponding to the first bit-plane data in the display device to return to a target state, and completing loading of a second bit-plane data while maintaining the pixel liquid crystal layer corresponding to the first bit-plane data in the target state. Based on the above method, the cost of data driving can be effectively reduced, and the display effect of the liquid crystal display device can be improved.

Abstract: Provided herein are compositions, which include an active pharmaceutical ingredient and macrogol 15 hydroxystearate, and methods for using the same for treating diseases or disorder.

Abstract: A display control circuit applies to a LCoS panel including pixel units and a substrate. The display control circuit includes a pixel memory array circuit and a driving circuit. The pixel memory array circuit includes pixel memory units. A projection of the pixel memory array circuit on the substrate is in a projection of the pixel units on the substrate. The driving circuit includes a row driving circuit and a column driving circuit. A projection of the driving circuit on the substrate is outside the projection of the pixel units on the substrate. The driving circuit provides a modulation signal and pixel data. The pixel memory array circuit modulates the pixel data by the modulation signal to provide a pixel display voltage to each of the pixel units.

Abstract: A management server for providing behavioral habit improvement includes a communication module, a memory configured to store a behavioral habit improvement service providing program, and a processor configured to execute the program, wherein the processor executes the program to provide a user terminal with a user interface that allows an input of behavior pattern information including behavioral habits, a trigger, and a solution, and period information for implementing the behavior pattern information, to match the behavior pattern information, the period information, and user identification information input from the user terminal, to store the matched information in a database, to generate a behavior pattern feed that displays the behavioral habits, the trigger, and the solution on one screen, and to provide the behavior pattern feed through the user interface.

Abstract: Imaging agents comprising an isolated polypeptide conjugated with a radionucleide and a chelator; wherein the isolated polypeptide binds specifically to HER2, or a variant thereof; and methods for preparing and using these imaging agents.

Abstract: Methods and systems for releasing growth factors are disclosed. In certain embodiments, a blood sample is exposed to a sequence of one or more electric pulses to trigger release of a growth factor in the sample. In certain embodiments, the growth factor release is not accompanied by clotting within the blood sample.

Abstract: The present disclosure relates to an advanced in vivo reprogramming system and a cell conversion method using same. The reprogramming system of the present disclosure comprises a start cell marker promoter, a pluripotency-maintaining gene protein, an amino acid isolation peptide, Cre recombinase, a target cell marker promoter, LoxP, and a gene encoding a fluorescent protein, does not require cell fixation in order to confirm cell conversion, enables real-time monitoring in a living cell state, and may be used both in vitro and in vivo. Therefore, the present disclosure is expected to be widely used in the biological and medical fields.

Abstract: Methods and systems for releasing growth factors are disclosed. In certain embodiments, a blood sample is exposed to a sequence of one or more electric pulses to trigger release of a growth factor in the sample. In certain embodiments, the growth factor release is not accompanied by clotting within the blood sample.

Abstract: A display control circuit applies to a LCoS panel including pixel units and a substrate. The display control circuit includes a pixel memory array circuit and a driving circuit. The pixel memory array circuit includes pixel memory units. A projection of the pixel memory array circuit on the substrate is in a projection of the pixel units on the substrate. The driving circuit includes a row driving circuit and a column driving circuit. A projection of the driving circuit on the substrate is outside the projection of the pixel units on the substrate. The driving circuit provides a modulation signal and pixel data. The pixel memory array circuit modulates the pixel data by the modulation signal to provide a pixel display voltage to each of the pixel units.

Abstract: A semiconductor device includes a substrate and first and second gate electrodes on the substrate. The first gate electrode includes a first gate insulation film having a bottom portion on the substrate and sidewall portions extending from the bottom portion and away from the substrate defining a first trench having a first width and a first functional film filling the first trench. The second gate electrode includes a second gate insulation film having a bottom portion on the substrate and sidewall portions extending from the bottom portion defining a second trench having a second width different from the first width, a second functional film conforming to the second gate insulation film in the second trench and defining a third trench, and a metal region in the third trench. The first width may be less than the second width.

Abstract: Provided herein are compositions, which include an active pharmaceutical ingredient and macrogol 15 hydroxystearate, and methods for using the same for treating diseases or disorder.

Abstract: Imaging agents comprising an isolated polypeptide conjugated with a radionucleide and a chelator; wherein the isolated polypeptide binds specifically to HER2, or a variant thereof; and methods for preparing and using these imaging agents.

Abstract: A method of fabricating a semiconductor device includes forming an interlayer dielectric on a substrate, the interlayer dielectric including first and second openings respectively disposed in first and second regions formed separately in the substrate; forming a first conductive layer filling the first and second openings; etching the first conductive layer such that a bottom surface of the first opening is exposed and a portion of the first conductive layer in the second opening remains; and forming a second conductive layer filling the first opening and a portion of the second opening.